SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019687-15-001655
Filing Date
2015-04-29
Accepted
2015-04-29 09:00:19
Documents
3
Period of Report
2015-04-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k-042815.htm 8-K 14411
2 AGREEMENT LETTER pharmacyte_8k-ex1001.htm EX-10.1 32684
3 GRAPHIC image_001.gif GRAPHIC 5644
  Complete submission text file 0001019687-15-001655.txt   56452
Mailing Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643
Business Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 333-68008 | Film No.: 15810267
SIC: 2833 Medicinal Chemicals & Botanical Products